-
1
-
-
10944256241
-
Cerebral tolerance: A promising choice towards new treatments for neurologic diseases
-
Blondeau N, Heurteaux C. Cerebral tolerance: a promising choice towards new treatments for neurologic diseases. Med Sci, 2004, 20: 1109-1114.
-
(2004)
Med Sci
, vol.20
, pp. 1109-1114
-
-
Blondeau, N.1
Heurteaux, C.2
-
2
-
-
0024494427
-
Reversible middle cerebral allery occlusion without eranieetomy in rats
-
Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral allery occlusion without eranieetomy in rats. Stroke, 1989, 20: 84-91.
-
(1989)
Stroke
, vol.20
, pp. 84-91
-
-
Longa, E.Z.1
Weinstein, P.R.2
Carlson, S.3
-
3
-
-
0035075998
-
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats
-
Chen JL, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke, 2001, 32: 1005-1011.
-
(2001)
Stroke
, vol.32
, pp. 1005-1011
-
-
Chen, J.L.1
Li, Y.2
Wang, L.3
-
4
-
-
0036249884
-
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro
-
Konstantin P, Karsten R, Maria K, et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab, 2002, 22: 520-524.
-
(2002)
J Cereb Blood Flow Metab
, vol.22
, pp. 520-524
-
-
Konstantin, P.1
Karsten, R.2
Maria, K.3
-
5
-
-
16644380412
-
Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site
-
Rossler J, Stolze I, Frede S, et al. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J Cell Biochem, 2004, 93: 153-161.
-
(2004)
J Cell Biochem
, vol.93
, pp. 153-161
-
-
Rossler, J.1
Stolze, I.2
Frede, S.3
-
6
-
-
0033763820
-
Expression of hypoxia-inducible factor-1 alpha in the brain of rats during chronic hypoxia
-
Chavez JC, Agani F, Pichiule P, et al. Expression of hypoxia-inducible factor-1 alpha in the brain of rats during chronic hypoxia. J Appl Physiol, 2000, 89: 1937-1942.
-
(2000)
J Appl Physiol
, vol.89
, pp. 1937-1942
-
-
Chavez, J.C.1
Agani, F.2
Pichiule, P.3
-
7
-
-
84861115235
-
-
Chinese source
-
2007, 23: 448-452.
-
(2007)
, vol.23
, pp. 448-452
-
-
-
8
-
-
84861109766
-
-
Chinese source
-
2005, 26: 288-290.
-
(2005)
, vol.26
, pp. 288-290
-
-
-
9
-
-
20844431565
-
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders
-
Freeman RS, Barone MC. Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr Drug Targets CNS Neurol Disord, 2005, 4: 85-92.
-
(2005)
Curr Drug Targets CNS Neurol Disord
, vol.4
, pp. 85-92
-
-
Freeman, R.S.1
Barone, M.C.2
-
10
-
-
0042122371
-
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin
-
Prass K, Scharff A, Ruscher K, et al. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke, 2003, 34: 1981-1986.
-
(2003)
Stroke
, vol.34
, pp. 1981-1986
-
-
Prass, K.1
Scharff, A.2
Ruscher, K.3
-
11
-
-
34247468355
-
Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice
-
Li Y, Lu Z, Keogh CL, et al. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab, 2007, 27: 1043-1054.
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, pp. 1043-1054
-
-
Li, Y.1
Lu, Z.2
Keogh, C.L.3
-
12
-
-
20444430402
-
Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin
-
Liu J, Narasimhan P, Yu F, et al. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke, 2005, 36: 1264-1269.
-
(2005)
Stroke
, vol.36
, pp. 1264-1269
-
-
Liu, J.1
Narasimhan, P.2
Yu, F.3
|